486–487
recording procedures for, 487
related to route of administration and 
speed of substance effects, 486
substance/medication-induced mental 
disorders, 481, 487–490
development and course of, 489
features of, 488–489
functional consequences of, 490
recording procedures for, 490
tobacco-related, 575–576
Substance intoxication delirium, 596–597, 598
Substance/medication-ind uced anxiety disorder, 
190, 226–230
associated features supporting diagnosis of, 
228–229diagnostic criteria for, 226–227
diagnostic features of, 228
diagnostic markers for, 229
differential diagnosis of, 229–230
prevalence of, 229
recording procedures for, 227–228
Substance/medication-induced bipolar and 
related disorder, 123, 142–145
associated features supporting diagnosis of, 144
comorbidity with, 146
development and course of, 144–145
diagnostic criteria for, 142–143
diagnostic features of, 144
diagnostic markers for, 145
differential diagnosis of, 145
prevalence of, 144
recording procedures for, 143–144
Substance/medication-induced depressive 
disorder, 155, 175–180
comorbidity with, 180
development and course of, 178
diagnostic criteria for, 175–176
diagnostic features of, 177–178
diagnostic markers for, 179
differential diagnosis of, 179–180
prevalence of, 178
recording procedures for, 176–177
risk and prognostic factors for, 178–179